» Articles » PMID: 37071130

The Effects of Serotonergic Psychedelics in Synaptic and Intrinsic Properties of Neurons in Layer II/III of the Orbitofrontal Cortex

Overview
Specialty Pharmacology
Date 2023 Apr 18
PMID 37071130
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Serotonergic psychedelics show promise in the treatment of psychiatric disorders, including obsessive-compulsive disorder. Dysfunction of the orbitofrontal cortex (OFc) has been implicated in the pathophysiology of compulsive behavior, which might be a key region for the efficacy of psychedelics. However, the effects of psychedelics on the neural activities and local excitation/inhibition (E/I) balance in the OFc are unclear.

Objectives: This study aimed to investigate how 25C-NBOMe, a substituted phenethylamine psychedelic, regulated the synaptic and intrinsic properties of neurons in layer II/III of the OFc.

Methods: Acute brain slices containing the OFc of adult male Sprague Dawley rats were used for ex vivo whole-cell recording. The synaptic and intrinsic properties of neurons were monitored using voltage and current clamps, respectively. Electrically evoked action potential (eAP) was used to measure synaptic-driven pyramidal activity.

Results: 25C-NBOMe enhanced spontaneous neurotransmission at glutamatergic synapses but diminished that in GABAergic synapses through the 5-HT receptor. 25C-NBOMe also increased both evoked excitatory currents and evoked action potentials. Moreover, 25C-NBOMe promoted the excitability of pyramidal neurons but not fast-spiking neurons. Either inhibiting G protein-gated inwardly rectifying potassium channels or activating protein kinase C significantly obstructed the facilitative effect of 25C-NBOMe on the intrinsic excitability of pyramidal neurons.

Conclusions: This work reveals the multiple roles of 25C-NBOMe in modulating synaptic and neuronal function in the OFc, which collectively promotes local E/I ratios.

Citing Articles

Psychedelic-Induced Neural Plasticity: A Comprehensive Review and a Discussion of Clinical Implications.

Weiss F, Magnesa A, Gambini M, Gurrieri R, Annuzzi E, Elefante C Brain Sci. 2025; 15(2).

PMID: 40002450 PMC: 11853016. DOI: 10.3390/brainsci15020117.


The effect of psilocybin on empathy and prosocial behavior: a proposed mechanism for enduring antidepressant effects.

Bhatt K, Weissman C Npj Ment Health Res. 2024; 3(1):7.

PMID: 38609500 PMC: 10955966. DOI: 10.1038/s44184-023-00053-8.


Neurotoxic effects of hallucinogenic drugs 25H-NBOMe and 25H-NBOH in organotypic hippocampal cultures.

Cassiano L, Oliveira M, De Barros W, de Fatima A, Coimbra R Heliyon. 2023; 9(7):e17720.

PMID: 37449113 PMC: 10336585. DOI: 10.1016/j.heliyon.2023.e17720.

References
1.
Araneda R, Andrade R . 5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience. 1991; 40(2):399-412. DOI: 10.1016/0306-4522(91)90128-b. View

2.
Athilingam J, Ben-Shalom R, Keeshen C, Sohal V, Bender K . Serotonin enhances excitability and gamma frequency temporal integration in mouse prefrontal fast-spiking interneurons. Elife. 2017; 6. PMC: 5746342. DOI: 10.7554/eLife.31991. View

3.
Barre A, Berthoux C, De Bundel D, Valjent E, Bockaert J, Marin P . Presynaptic serotonin 2A receptors modulate thalamocortical plasticity and associative learning. Proc Natl Acad Sci U S A. 2016; 113(10):E1382-91. PMC: 4791007. DOI: 10.1073/pnas.1525586113. View

4.
Best A, Regehr W . Serotonin evokes endocannabinoid release and retrogradely suppresses excitatory synapses. J Neurosci. 2008; 28(25):6508-15. PMC: 2720684. DOI: 10.1523/JNEUROSCI.0678-08.2008. View

5.
Carhart-Harris R, Goodwin G . The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology. 2017; 42(11):2105-2113. PMC: 5603818. DOI: 10.1038/npp.2017.84. View